Regeneron Pharmaceuticals, Inc.: Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients

Patients treated with olatorepatide achieved up to 19% body-weight loss at week 48 Regeneron's global Phase 3 registrational program to be initiated later this year TARRYTOWN, N.Y., March 09, 2026 (GL ...

Crisis Text Line Launches Partnership with Raregivers to Help Expand Free, 24/7 Mental Health Support for People in Need

NEW YORK, CA, UNITED STATES, March 9, 2026 /EINPresswire.com/ -- Crisis Text Line has partnered with Raregivers Inc, a ...

Single-Cell Atlas Reveals Why Rotator Cuff Injuries Heal with Damaging Scars

Researchers uncover how distinct cell populations and fibrotic signals drive permanent scarring after rotator cuff ...

Growing Industrial Demand Puts Top Power Slip Rings Manufacturers in the Spotlight

SHENZHEN CITY, GUANGDONG PROVINCE, CHINA, March 9, 2026 /EINPresswire.com/ -- The global slip ring market has entered a ...